|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
357,741,000 |
Market
Cap: |
133.31(B) |
Last
Volume: |
2,314,661 |
Avg
Vol: |
1,355,641 |
52
Week Range: |
$258.49 - $400.59 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
|
NASDAQ-100 |
|
S&P 400 MIDCAP |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 1071 |
Guru Rank Value : -4.4 |
Guru Occurances : 3 |
|
|
|
|
|
|
|
Company Profile Intuitive Surgical develops, manufactures, and markets the da Vinci® Surgical System and the Ion® endoluminal system. The systems consist of a surgeon console or consoles, a patient-side cart, a vision system, and proprietary instruments and accessories. Co.'s technology is designed to provide surgeons with a range of articulation of the surgical instruments used in the surgical field analogous to the motions of a human wrist, while filtering out the tremor inherent in a surgeon's hand. Co.'s platform for robotic-assisted surgery, da Vinci Surgical System, allows surgeons to operate while seated at a ergonomic console viewing a three-dimensional, high definition image of the surgical field.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
21,047 |
282,612 |
397,629 |
792,484 |
Total Sell Value |
$8,159,111 |
$108,998,780 |
$143,770,834 |
$244,205,489 |
Total People Sold |
7 |
12 |
13 |
13 |
Total Sell Transactions |
19 |
43 |
55 |
85 |
End Date |
2024-04-07 |
2024-01-05 |
2023-07-07 |
2022-07-07 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Guthart Gary S |
President & CEO |
|
2023-02-28 |
4 |
D |
$229.39 |
$724,643 |
D/D |
(3,159) |
30,532 |
|
- |
|
Guthart Gary S |
President & CEO |
|
2023-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,371 |
31,775 |
|
- |
|
Desantis Robert |
EVP & Chief Product Officer |
|
2023-02-26 |
4 |
D |
$231.05 |
$115,756 |
D/D |
(501) |
7,454 |
|
- |
|
Desantis Robert |
EVP & Chief Product Officer |
|
2023-02-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,590 |
7,955 |
|
- |
|
Charlton Henry L |
Senior Vice President & Chief |
|
2023-02-26 |
4 |
D |
$231.05 |
$89,416 |
D/D |
(387) |
19,059 |
|
- |
|
Charlton Henry L |
Senior Vice President & Chief |
|
2023-02-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,284 |
19,446 |
|
- |
|
Guthart Gary S |
President & CEO |
|
2023-02-26 |
4 |
D |
$231.05 |
$334,791 |
D/D |
(1,449) |
27,320 |
|
- |
|
Guthart Gary S |
President & CEO |
|
2023-02-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,030 |
28,769 |
|
- |
|
Widman Fredrik |
VP Corporate Controller |
|
2023-02-26 |
4 |
D |
$231.05 |
$48,983 |
D/D |
(212) |
2,002 |
|
- |
|
Widman Fredrik |
VP Corporate Controller |
|
2023-02-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
609 |
2,214 |
|
- |
|
Rosa David J. |
EVP Chief Strategy & Growth Of |
|
2023-02-26 |
4 |
D |
$231.05 |
$195,930 |
D/D |
(848) |
127,381 |
|
- |
|
Rosa David J. |
EVP Chief Strategy & Growth Of |
|
2023-02-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,710 |
128,229 |
|
- |
|
Myriam Curet |
EVP & Chief Medical Officer |
|
2023-02-26 |
4 |
D |
$231.05 |
$136,782 |
D/D |
(592) |
1,445 |
|
- |
|
Myriam Curet |
EVP & Chief Medical Officer |
|
2023-02-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,710 |
2,037 |
|
- |
|
Samath Jamie |
Chief Financial Officer |
|
2023-02-26 |
4 |
D |
$231.05 |
$102,817 |
D/D |
(445) |
4,814 |
|
- |
|
Samath Jamie |
Chief Financial Officer |
|
2023-02-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,284 |
5,259 |
|
- |
|
Mohr Marshall |
Executive VP Global Business S |
|
2023-02-26 |
4 |
D |
$231.05 |
$195,930 |
D/D |
(848) |
22,494 |
|
- |
|
Mohr Marshall |
Executive VP Global Business S |
|
2023-02-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,710 |
23,342 |
|
- |
|
Widman Fredrik |
VP Corporate Controller |
|
2023-02-16 |
4 |
AS |
$240.77 |
$27,929 |
D/D |
(116) |
1,605 |
|
- |
|
Desantis Robert |
EVP & Chief Product Officer |
|
2023-02-16 |
4 |
AS |
$240.77 |
$474,558 |
D/D |
(1,971) |
6,365 |
|
- |
|
Myriam Curet |
EVP & Chief Medical Officer |
|
2023-02-16 |
4 |
AS |
$240.77 |
$270,625 |
D/D |
(1,124) |
327 |
|
- |
|
Charlton Henry L |
Senior Vice President & Chief |
|
2023-02-15 |
4 |
D |
$244.77 |
$101,090 |
D/D |
(413) |
18,162 |
|
- |
|
Charlton Henry L |
Senior Vice President & Chief |
|
2023-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,311 |
18,575 |
|
- |
|
Rosa David J. |
EVP Chief Strategy & Growth Of |
|
2023-02-15 |
4 |
D |
$244.77 |
$273,163 |
D/D |
(1,116) |
126,519 |
|
- |
|
Rosa David J. |
EVP Chief Strategy & Growth Of |
|
2023-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,250 |
127,635 |
|
- |
|
1371 Records found
|
|
Page 10 of 55 |
|
|